SEC Comment Letter 0000000000-24-003291 to Silvaco Group, Inc. (SVCO)
Silvaco Group, Inc.
Date: March 26, 2024 · CIK: 0001943289 · Accession: 0000000000-24-003291
AI Filing Summary & Sentiment
Reasoning
Letter
United States securities and exchange commission logo March 26, 2024 Dr. Babak A. Taheri Chief Executive Officer Silvaco Group, Inc. 4701 Patrick Henry Drive, Building #23 Santa Clara, CA 95054 Re:Silvaco Group, Inc. Amendment No. 6 to Draft Registration Statement on Form S-1 Submitted March 18, 2024 CIK No. 0001943289 Dear Dr. Babak A. Taheri: We have reviewed your amended draft registration statement and have the following comment. Please respond to this letter by providing the requested information and either submitting an amended draft registration statement or publicly filing your registration statement on EDGAR. If you do not believe a comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing the information you provide in response to this letter and your amended draft registration statement or filed registration statement, we may have additional comments. Amendment No. 6 to Draft Registration Statement on Form S-1 Use of Proceeds, page 53 1.We note that the company intends to use a portion of the offering proceeds to repay the 2022 Credit Line and the East West Bank Loan. Please expand your disclosure to include the interest rates and maturity of such indebtedness. Refer to Item 504 of Regulation S-K.
FirstName LastNameDr. Babak A. Taheri Comapany NameSilvaco Group, Inc. March 26, 2024 Page 2 FirstName LastName Dr. Babak A. Taheri Silvaco Group, Inc. March 26, 2024 Page 2 Please contact Joseph Kempf at 202-551-3352 or Robert Littlepage at 202-551-3361 if you have questions regarding comments on the financial statements and related matters. Please contact Alexandra Barone at 202-551-8816 or Matthew Crispino at 202-551-3456 with any other questions. Sincerely, Division of Corporation Finance Office of Technology cc: Drew Valentine
Show Raw Text
United States securities and exchange commission logo
March 26, 2024
Dr. Babak A. Taheri
Chief Executive Officer
Silvaco Group, Inc.
4701 Patrick Henry Drive, Building #23
Santa Clara, CA 95054
Re:Silvaco Group, Inc.
Amendment No. 6 to Draft Registration Statement on Form S-1
Submitted March 18, 2024
CIK No. 0001943289
Dear Dr. Babak A. Taheri:
We have reviewed your amended draft registration statement and have the following
comment.
Please respond to this letter by providing the requested information and either submitting
an amended draft registration statement or publicly filing your registration statement on
EDGAR. If you do not believe a comment applies to your facts and circumstances or do not
believe an amendment is appropriate, please tell us why in your response.
After reviewing the information you provide in response to this letter and your amended
draft registration statement or filed registration statement, we may have additional comments.
Amendment No. 6 to Draft Registration Statement on Form S-1
Use of Proceeds, page 53
1.We note that the company intends to use a portion of the offering proceeds to repay the
2022 Credit Line and the East West Bank Loan. Please expand your disclosure to include
the interest rates and maturity of such indebtedness. Refer to Item 504 of Regulation S-K.
FirstName LastNameDr. Babak A. Taheri
Comapany NameSilvaco Group, Inc.
March 26, 2024 Page 2
FirstName LastName
Dr. Babak A. Taheri
Silvaco Group, Inc.
March 26, 2024
Page 2
Please contact Joseph Kempf at 202-551-3352 or Robert Littlepage at 202-551-3361 if
you have questions regarding comments on the financial statements and related matters. Please
contact Alexandra Barone at 202-551-8816 or Matthew Crispino at 202-551-3456 with any other
questions.
Sincerely,
Division of Corporation Finance
Office of Technology
cc: Drew Valentine